M

Magle Chemoswed Holding AB
STO:MAGLE

Watchlist Manager
Magle Chemoswed Holding AB
STO:MAGLE
Watchlist
Price: 32.6 SEK -4.12% Market Closed
Market Cap: 599.9m SEK
Have any thoughts about
Magle Chemoswed Holding AB?
Write Note

Magle Chemoswed Holding AB
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Magle Chemoswed Holding AB
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
M
Magle Chemoswed Holding AB
STO:MAGLE
Change in Working Capital
-kr11.9m
CAGR 3-Years
16%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Change in Working Capital
-kr274m
CAGR 3-Years
N/A
CAGR 5-Years
-30%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Change in Working Capital
kr133.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Change in Working Capital
-kr119m
CAGR 3-Years
N/A
CAGR 5-Years
-8%
CAGR 10-Years
-20%
G
Genovis AB
STO:GENO
Change in Working Capital
kr2.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Change in Working Capital
-kr67.6m
CAGR 3-Years
0%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
No Stocks Found

Magle Chemoswed Holding AB
Glance View

Market Cap
599.9m SEK
Industry
Life Sciences Tools & Services

Magle Chemoswed Holding AB engages in the provision of contract development and manufacturing services to the pharmaceutical and medical device industry. The company is headquartered in Malmo, Skane. The company went IPO on 2020-06-30. The firm's operations are mainly conducted through the subsidiaries Magle Chemoswed AB and Adroit Science AB. The business is focused on process development and manufacturing of Active Pharmaceutical Ingredients (API) as well as research, development and manufacturing of products in the areas of wound care and diagnostics with particular focus on products based on degradables starch microspheres. Magle Chemoswed also functions as a consultancy in material characterization and solid phase analysis with a main focus on pharmaceutical companies.

MAGLE Intrinsic Value
83.52 SEK
Undervaluation 61%
Intrinsic Value
Price
M

See Also

What is Magle Chemoswed Holding AB's Change in Working Capital?
Change in Working Capital
-11.9m SEK

Based on the financial report for Dec 31, 2023, Magle Chemoswed Holding AB's Change in Working Capital amounts to -11.9m SEK.

What is Magle Chemoswed Holding AB's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
-2%

Over the last year, the Change in Working Capital growth was 13%. The average annual Change in Working Capital growth rates for Magle Chemoswed Holding AB have been 16% over the past three years , -2% over the past five years .

Back to Top